Western Oregon is seeing public building closures, travel restrictions, and school closures as a result of the severe weather conditions in the area. We will continue to update as we
Use of an antibody drug conjugate and a PD-1 inhibitor brings complementary mechanisms together while eliminating the most toxic agent that has been used in combinations to treat classic Hodgkin lymphoma (cHL).
Acalabrutinib, as monotherapy or in combination with obinutuzumab, continued to improve progression-free survival vs obinutuzumab and chemotherapy in patients with treatment-naive chronic lymphocytic leukemia, regardless of genomic marker status.
Lane County cancer institute first to offer Truebeam radiotherapy kpic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kpic.com Daily Mail and Mail on Sunday newspapers.